Latest Gastrointestinal cancer Stories

Instructional program can cut no-shows rates Patients who watch an online instructional video are more likely to keep their appointments and arrive prepared for a scheduled colonoscopy than those who do not, according to a study by gastroenterologists at the University of Chicago Medicine. The study, presented at the 2012 annual Digestive Diseases Week meeting in San Diego, CA, found that among patients age 50 to 65 – the primary target for colon cancer screening – those who watched...

STONYBROOK, N.Y., May 21, 2012 /PRNewswire/ -- Viatronix Incorporated, a leading innovator and developer of 2D/3D medical imaging and diagnostic software today announced that their V3D®-Colon platform was exclusively used to perform a key study recently published in the Annals of Internal Medicine. The purpose of the study was to determine the feasibility of a laxative free bowel prep for patients undergoing a virtual colonoscopy (VC), screening exam. The trial utilized a modified...

3-pronged study reveals high response rate in other advanced melanoma patients and activity in multiple cancers An experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients in part of an international phase I clinical trial report in the May 18 issue of The Lancet. The drug dabrafenib, which targets the Val600 BRAF mutation that is active in half of melanoma cases, also cut the size of tumors in 25 of 36...

NATICK, Mass., May 18, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces that seven abstracts and additional clinical data analyses will be presented at Digestive Disease Week(®) (DDW), May 19 - 22 in San Diego. The analyses involve the SpyGlass(®) Direct Visualization System, WallFlex® Biliary RX Stent, Expect(TM) 19 Flex Endoscopic Ultrasound Aspiration Needle and Resolution® Clip. "The volume and quality of presentations that include Boston Scientific...

Mount Sinai School of Medicine researchers will present several landmark studies, including data on treatment trends in late-stage cancer, HPV-positive head and neck cancer, a promising multiple myeloma vaccine, and predictive models of soft tissue sarcomas, prostate and bladder cancer, at the 2012 American Society of Clinical Oncology (ASCO) meeting June 1-5, 2012 in Chicago. New York, NY (PRWEB) May 17, 2012 Mount Sinai School of Medicine researchers will present several landmark...

Landmark research presented at annual cancer meeting Mount Sinai School of Medicine researchers will present several landmark studies, including data on treatment trends in late-stage cancer, a promising multiple myeloma vaccine, and predictive models of soft tissue sarcomas, prostate and bladder cancer, at the 2012 American Society of Clinical Oncology (ASCO) meeting June 1-5, 2012 in Chicago. Highlights of Mount Sinai research at ASCO: Age, Race, Lower Income, and Lack of...

Screening lung cancer tumor samples for cancer-causing, or "driver," genetic mutations can help physicians tailor patients' treatments to target those specific mutations. While scientists have identified cancer-causing mutations for the majority of lung adenocarcinomas — the most common type of non-small cell lung cancer — and have developed drugs that can successfully address them, scientists have not yet identified targeted therapies for another type of non-small cell lung cancer known...

THOUSAND OAKS, Calif., May 16, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced today results from an exploratory biomarker analysis evaluating MET expression as a predictor of clinical response to rilotumumab (AMG 102). This analysis, conducted on a previously reported Phase 2 study of rilotumumab in patients with locally advanced or metastatic gastric or gastroesophageal cancer, showed that treatment with rilotumumab in combination with chemotherapy improved median overall...

SAN FRANCISCO, Calif., May 16, 2012 /PRNewswire/ -- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer will be covered in three separate abstracts released today by the American Society of Clinical Oncology (ASCO). The data relate to completed and ongoing clinical trials of...

(Ivanhoe Newswire) – The mere thought of getting a standard colonoscopy makes some people shudder in their seats, and unfortunately, prevents many people from receiving the critically important check-up. But there is a new procedure that may make the whole process a bit easier to endure. Typically, the standard optical colonoscopy involves the examination of the internal surface of the colon using a lit fiber-optic tube with a camera at the end. The preparation is what drives people away...